# Which approach fits US banks, healthcare organisations and public companies?

**Sector requirements should change the demonstration—not merely the supplier’s presentation deck.** Use legal and regulatory specialists to confirm applicability. The tests below are procurement recommendations, not legal opinions.

| Buyer segment | Primary-source basis | Comparison implication | Recommended scenario |
|---|---|---|---|
| **Banks and lenders** | The banking agencies’ third-party guidance covers planning, due diligence and selection, contract negotiation, monitoring and termination. ([occ.gov](https://www.occ.gov/news-issuances/news-releases/2023/nr-ia-2023-53.html?utm_source=openai)) | Compare the full vendor-risk lifecycle, not only questionnaire scoring | A critical supplier changes service scope, develops a material issue and must be exited |
| **Healthcare providers and health plans** | HHS guidance addresses risks to all e-PHI created, received, maintained or transmitted and says the Security Rule does not prescribe one risk-analysis methodology. ([hhs.gov](https://www.hhs.gov/hipaa/for-professionals/security/guidance/guidance-risk-analysis/index.html)) | Test scoping and risk-analysis completeness rather than accepting a framework checklist | A clinical service, its technology and an external supplier share a dependency requiring remediation |
| **Public companies and SOX programmes** | PCAOB AS 2201 distinguishes design effectiveness, operating effectiveness and the evidence necessary to support conclusions. ([pcaobus.org](https://pcaobus.org/oversight/standards/auditing-standards/details/AS2201?utm_source=openai)) | Evaluate test design, evidence, review and deficiency handling separately | Evidence is collected successfully but does not demonstrate the control operated as intended |
| **Internal-audit-led programmes** | The IIA’s Standard 7.1 addresses organisational independence and safeguards against impairment. ([theiia.org](https://www.theiia.org/globalassets/site/standards/globalinternalauditstandards_2024january9.pdf)) | Shared data must not erase independent judgement or appropriate reporting relationships | Management challenges a finding but cannot overwrite the audit conclusion |

For **mid-sized banks**, include a sector-oriented comparator where its scope matches the need. Ncontracts publishes banking-specific enterprise risk, vendor management, compliance and findings-management offerings. Its existence is a reason to test a financial-services operating model against a broader suite—not evidence that it is best for every bank. ([ncontracts.com](https://www.ncontracts.com/bank-risk-management?utm_source=openai))

For **healthcare**, Censinet describes healthcare-focused third-party risk, enterprise risk, operational dependencies and AI governance. Include it where those workflows matter, while separately testing whether it covers the full intended programme. ([censinet.com](https://censinet.com/?utm_source=openai))

### Can shared controls preserve audit independence?

**Our recommendation is to share suitable source records while separating ownership of assessments and conclusions.** Organisational independence is a professional-governance requirement, not something a role-based access setting alone can establish. The IIA requires attention to reporting relationships and safeguards where responsibilities might impair independence. ([theiia.org](https://www.theiia.org/globalassets/site/standards/globalinternalauditstandards_2024january9.pdf))

In the platform, test whether:

- Management can maintain its control description without rewriting a completed audit assessment.
- Auditors can retain an independent test result against the same control.
- Evidence reuse preserves the scope, period, version and reviewing party.
- Reopening a finding leaves its prior state and approvals traceable.
- Sensitive investigations remain restricted even when aggregate reporting is shared.